Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?

TheFly reported connected June 25 that Guggenheim raised its terms people connected AMLX to $40 from $30 portion reaffirming its Buy rating. The steadfast besides elevated the banal to its Best Idea designation up of the anticipated Phase 3 LUCIDITY proceedings results for avexitide successful post-bariatric hypoglycemia, expected successful the 3rd quarter. Guggenheim expressed assurance that the pivotal survey volition nutrient favorable outcomes, supporting avexitide's commercialized prospects and positioning the therapy to seizure a important stock of the estimated $6 billion-plus U.S. post-bariatric hypoglycemia market.

Just 2 days prior, connected June 23, Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced the presumption of information from its first-in-human, dose-ranging Phase 1 LUMINA proceedings evaluating AMX0114 astatine the European Network to Cure ALS Meeting 2026. The survey showed that AMX0114 was not associated with drug-related superior adverse events oregon superior neurological adverse events successful Cohort 1. The information results enactment continued investigating of higher dose levels successful the ongoing aggregate ascending dose study. Biomarker assessments, including spectrin breakdown merchandise 145, neurofilament light, and phosphorylated neurofilament heavy, remained adjacent to baseline levels. Cohort 1 evaluated the lowest dose, with aboriginal cohorts planned to measure higher doses.

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is simply a clinical-stage biopharmaceutical institution processing therapies for neurodegenerative and uncommon diseases, focusing connected innovative treatments for conditions with precocious unmet aesculapian needs.

While we admit the imaginable of AMLX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.